Texas Passes Bills Expanding Medical Cannabis, Banning Hemp, and Supporting Psychedelics

Texas lawmakers recently shook up the state's cannabis landscape with a mix of expansion and restriction. The biggest blow is Senate Bill 3, which effectively bans the popular $8 billion delta-8 hemp industry, a move that could cost 50,000 jobs. On a brighter note, House Bill 46 expands the medical marijuana program by adding conditions like chronic pain and Crohn’s disease, while also allowing for more dispensers and better product variety. In a surprising turn, Texas is also diving into psychedelic research, funding a $50 million consortium to study ibogaine for mental health treatment.

For the everyday toker in Texas, this is a bittersweet moment. While the medical expansion is a win for accessibility and legitimacy, the hemp ban is a major step backward for those who rely on the ease and affordability of delta-8. It highlights the ongoing struggle between regulation and total prohibition. This matters because it forces consumers toward a still-limited medical market, reminding us that while progress is happening, the fight for fair and open access continues.